About Us


Dedicated to pharmaceutical raw materials, we lay the foundation for quality.

ABOUT US

Company Profile

Yichang Tianren Pharmaceutical Co., Ltd. was established in 2004 and is a wholly owned subsidiary of Yichang Humanwell Pharmaceutical. The company specializes in the research, development, production, and sales of chemical APIs and pharmaceutical intermediates. It operates five GMP‑compliant production lines with a total reaction volume exceeding 80 cubic meters, capable of meeting diverse needs from clinical-stage development to commercial-scale manufacturing. Its product portfolio spans antiviral, ED‑treatment, and anti‑infective therapeutic areas, with key products including valaciclovir hydrochloride, tadalafil, and arbidol. The company has been recognized with numerous accolades, including “High‑Tech Enterprise,” “Hubei Provincial Enterprise Technology Center,” and “Hubei Provincial Specialized, Refined, Distinctive, and Innovative ‘Little Giant’ Enterprise.” Looking ahead, the company will leverage GMP‑based management practices to develop differentiated API offerings, expand its CMO and CDMO businesses, and drive sustained growth.

2004 year

Company establishment date

40 +

R&D products and pipeline candidates

300 Tai+

Equipped with production line equipment

34354 ㎡

The total land area of Tianren Pharmaceutical Company is

Corporate culture

Between heaven and earth, benevolence comes first.

Corporate Mission: Create value through innovation and jointly serve human health.

Corporate Vision: To become a distinctive pharmaceutical enterprise with global competitiveness.
Corporate Core Values: United as One, Achieving Outstanding Results Together
Corporate Spirit: Unity, Efficiency, Resilience, Innovation

DEVELOPMENT HISTORY

Development History


A Chronology of Major Milestones in the Development of Yichang Tianren Pharmaceutical Co., Ltd.

2004
Early Founding Phase
Yichang Renfu Pharmaceutical Co., Ltd. contributed its proprietary manufacturing technologies for the two chemical APIs, pefloxacin mesylate and phenylpropanol, as its investment, and, together with several individual investors, jointly established the company.
2013
Steady Development Phase
Through independent research and development, we have successfully launched several new products, including valaciclovir hydrochloride, enoxacin gluconate, and telmisartan. The valaciclovir hydrochloride API has earned recognition from numerous domestic manufacturers thanks to its superior quality, capturing a significant market share and obtaining registration approvals in multiple countries; its products are now exported overseas. We have completed the R&D of seven APIs—levobupivacaine hydrochloride, pramipexole dihydrochloride, mirtazapine, and others—and have advanced them to the submission stage.
2019
Strategic Upgrade Phase
Due to urban development plans and growth requirements in the vicinity of Yichang East Railway Station, a comprehensive relocation has been undertaken, with a new multi‑functional API production base being constructed at the Yichang Bio‑Industry Park within the Wuhan National Bio‑Industry Base. The new facility occupies a site of 34,352.65 square meters and features a total floor area of 27,649 square meters.
2024
Period of rapid expansion
The company operates five GMP‑compliant production lines, each tailored to specific process requirements, with a combined reaction volume exceeding 80 cubic meters. These facilities can meet diverse API and intermediate manufacturing needs, ranging from early‑stage clinical development to commercial-scale production, spanning kilogram‑to‑ton quantities. To date, 13 products have successfully passed domestic GMP compliance inspections.
2026
Future Outlook
The company will continue to implement a rigorous GMP management system, focus on developing differentiated API products, and actively expand its CMO and CDMO businesses, thereby driving sustained, healthy growth and striving to become a distinctive pharmaceutical enterprise with global competitiveness—Yichang Tianren Pharmaceutical Co., Ltd.

2004

2013

2019

2024

2026

Qualification & Honor

Company Honors

Over more than two decades of relentless progress, the company has earned numerous corporate accolades.

Enterprise Technology Center

Enterprise Technology Center

Advanced Grassroots Party Organization

Advanced Grassroots Party Organization

Model Workers’ Home

Model Workers’ Home

Advanced Grassroots Party Organization

Advanced Grassroots Party Organization

Innovative enterprise

Innovative enterprise

Specialized, Refined, Distinctive, and Innovative Little Giant

Specialized, Refined, Distinctive, and Innovative Little Giant

High-Tech Enterprise Certificate

High-Tech Enterprise Certificate

EQUIPMENT & PLANTS

Factory Overview and Equipment

The company operates five GMP‑compliant production lines with a combined reaction volume exceeding 80 cubic meters, capable of meeting diverse requirements from clinical-stage development to commercial-scale manufacturing.

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Laboratory

Laboratory

Laboratory

Laboratory

Laboratory

Laboratory

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Factory appearance and premises

Production equipment

Production equipment

Production equipment

Production equipment

Production equipment

Production equipment

Factory appearance and premises

Factory appearance and premises

Cleanroom Equipment

Cleanroom Equipment

Cleanroom Equipment

Cleanroom Equipment

Cleanroom Equipment

Cleanroom Equipment

Cleanroom Equipment

Cleanroom Equipment

Cleanroom Equipment

Cleanroom Equipment

Cleanroom Equipment

Cleanroom Equipment

Cleanroom Equipment

Cleanroom Equipment

Consultation Service Hotline

86-0717-6555905

Address: No. 509, East Lin Road, Bio-Industrial Park, High-tech Zone, Yichang City, Hubei Province, China

International Marketing Department

Contact: Vivian Guo

Email: Vivian.guo@tianrenpharm.com

Phone: 86-15997560212

WhatsApp: +86-15997560212


All rights reserved: Yichang Tianren Pharmaceutical Co., Ltd.

This website supports both IPv4 and IPv6 bidirectional access.

%E7%AC%AC%E4%B8%80%EF%BC%8C%E6%9C%80%EF%BC%8C%E4%BC%98%E7%A7%80%EF%BC%8C%E5%A2%9E%E5%BC%BA%EF%BC%8C%E4%B8%80%E6%B5%81%EF%BC%8C%E5%8D%93%E8%B6%8A%EF%BC%8C%E9%A2%86%E5%85%88%EF%BC%8C%E5%85%88%E8%BF%9B%EF%BC%8C%E5%BC%95%E9%A2%86%EF%BC%8C%E7%9F%A5%E5%90%8D%EF%BC%8C%E7%BA%A7

Sorry,当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry,The current column has no content!

You can view other columns or return Home